BGLC 8-K 2026-06-05

BioNexus Gene Lab Corp (BGLC) 8-K dated 2026-06-05 — accession 0001477932-26-003658. This URL is the filing, not the BGLC hub.

BioNexus Gene Lab Corp (BGLC) is a specialty chemicals company listed on NASDAQ.

BioNexus Gene Lab Corp filed a 8-K on 2026-06-05. Accession 0001477932-26-003658.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BGLC revenue for 2026-06-30 was $99.0K. Net income was -$830.0K. BGLC currently screens at market cap $6.1M.

Not investment advice. The BGLC SEC hub lists recent forms. The stock page is the research view.